FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Saquinavir Mesylate (Invirase) 200mg Capsules
Status: Discontinuation
»Therapeutic Categories: Antiviral

Genentech, Inc (New 02/06/2018)

Company Contact Information:

Presentation Posting Date Related Information
200 mg capsules (NDC 0004-0245-15) 02/06/2018 Roche intends to stop-shipping Saquinavir Mesylate (Invirase) 200 mg Capsules on March 31, 2018 with product availability continuing until the September 2018 expiry date. Saquinavir Mesylate (Invirase) 500mg Tablets are still available. This discontinuation is not due to manufacturing, product quality, safety or efficacy concerns.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English